Medications

Elan enters $1B royalty deal with Theravance

Irish drugmaker Elan Corp. PLC plans to pay $1 billion for the right to future royalties from four respiratory treatments being developed by Theravance Inc. and GlaxoSmithKline.

Diseases, Conditions, Syndromes

Accurate lung model will allow asthmatics to breathe easy

Curtin University researchers have taken large strides towards revolutionising drug delivery for asthmatics and people with lung diseases, potentially saving thousands of lives and millions of dollars.

Diseases, Conditions, Syndromes

Doctors answer your questions about RSV

While a potential COVID winter surge and the impending flu season get a lot of attention, doctors are worried about another virus.

Diseases, Conditions, Syndromes

Comorbidities predict positive RT-PCR testing

Researchers at CDDEP, University of California, Berkeley, and the Government of Tamil Nadu recently published 'SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, South India: a prospective, active ...

Diseases, Conditions, Syndromes

Inhaled corticosteroids raise pneumonia risk

A University of Alberta researcher says health professionals should be cautious about prescribing inhaled corticosteroids to high-risk patients such as pneumonia survivors, citing a twofold risk for repeat infection.

Health

Queering environmental justice

Discrimination of the LGBTQ+ community in the United States is well documented, though the public discourse tends to focus on interpersonal acts of bigotry and legislative debates. What has received less attention, however, ...

page 18 from 23